The Patent Finder

(N-(CYANOMETHYL)-4-(2-(4-Morpholinophenylamino)PYRIMIDIN-4-YL)BENZAMIDE

GlaxoSmithKline LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 14/736,690, filed Jun 11, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,809,559(N-(CYANOMETHYL)-4-(2-(4-Morpholinophenylamino)PYRIMIDIN-4-YL)BENZAMIDE
In force
 · Medium confidence
GlaxoSmithKline LLCIn force
Medium confidence
US RE48,285N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) Benzamide
In force
 · Low confidence
GlaxoSmithKline LLCIn force
Low confidence
US RE49,445N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) Benzamide
In force
 · Low confidence
GlaxoSmithKline LLCIn force
Low confidence
US RE50,497(N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-y l)Benzamide
In force
 · Low confidence
GlaxoSmithKline LLCIn force
Low confidence
US 9,469,613(N-(CYANOMETHYL)-4-(2-(4-Morpholinophenylamino)PYRIMIDIN-4-YL)BENZAMIDE
Surrendered on reissue Oct 27, 2020
Surrendered on reissue Oct 27, 2020 · High confidence
GlaxoSmithKline LLCSurrendered on reissue Oct 27, 2020Surrendered on reissue Oct 27, 2020
High confidence
Application 19/245,507(N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-y l)Benzamide
Pending
Not granted
GlaxoSmithKline LLCPendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited